nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—Hepatic function abnormal—Pamidronate—Paget's disease of bone	0.00515	0.00586	CcSEcCtD
Dipyridamole—Dysphagia—Alendronate—Paget's disease of bone	0.0051	0.0058	CcSEcCtD
Dipyridamole—Asthenia—Tiludronate—Paget's disease of bone	0.0051	0.0058	CcSEcCtD
Dipyridamole—ADA—Validated transcriptional targets of TAp63 isoforms—PML—Paget's disease of bone	0.00493	0.0409	CbGpPWpGaD
Dipyridamole—Abdominal discomfort—Alendronate—Paget's disease of bone	0.00489	0.00556	CcSEcCtD
Dipyridamole—Arthritis—Risedronate—Paget's disease of bone	0.00487	0.00554	CcSEcCtD
Dipyridamole—Diarrhoea—Tiludronate—Paget's disease of bone	0.00487	0.00553	CcSEcCtD
Dipyridamole—Atrial fibrillation—Pamidronate—Paget's disease of bone	0.00475	0.0054	CcSEcCtD
Dipyridamole—Dizziness—Tiludronate—Paget's disease of bone	0.0047	0.00535	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Pamidronate—Paget's disease of bone	0.00465	0.00529	CcSEcCtD
Dipyridamole—Eye pain—Zoledronate—Paget's disease of bone	0.00456	0.00518	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Pamidronate—Paget's disease of bone	0.0045	0.00512	CcSEcCtD
Dipyridamole—Headache—Tiludronate—Paget's disease of bone	0.00445	0.00507	CcSEcCtD
Dipyridamole—ADA—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.00444	0.0368	CbGpPWpGaD
Dipyridamole—Atrial fibrillation—Zoledronate—Paget's disease of bone	0.00434	0.00494	CcSEcCtD
Dipyridamole—Abdominal pain upper—Risedronate—Paget's disease of bone	0.00433	0.00492	CcSEcCtD
Dipyridamole—Thirst—Zoledronate—Paget's disease of bone	0.00432	0.00492	CcSEcCtD
Dipyridamole—Alopecia—Etidronic acid—Paget's disease of bone	0.00424	0.00482	CcSEcCtD
Dipyridamole—Arthritis—Zoledronate—Paget's disease of bone	0.00423	0.00481	CcSEcCtD
Dipyridamole—Nausea—Tiludronate—Paget's disease of bone	0.00422	0.0048	CcSEcCtD
Dipyridamole—Flatulence—Etidronic acid—Paget's disease of bone	0.00411	0.00468	CcSEcCtD
Dipyridamole—Haemoglobin—Alendronate—Paget's disease of bone	0.00411	0.00467	CcSEcCtD
Dipyridamole—Haemorrhage—Alendronate—Paget's disease of bone	0.00408	0.00464	CcSEcCtD
Dipyridamole—Cramp muscle—Pamidronate—Paget's disease of bone	0.00406	0.00461	CcSEcCtD
Dipyridamole—Muscle spasms—Etidronic acid—Paget's disease of bone	0.00401	0.00456	CcSEcCtD
Dipyridamole—Angina pectoris—Risedronate—Paget's disease of bone	0.00399	0.00454	CcSEcCtD
Dipyridamole—Abdominal discomfort—Risedronate—Paget's disease of bone	0.00393	0.00446	CcSEcCtD
Dipyridamole—Anaemia—Etidronic acid—Paget's disease of bone	0.00386	0.00439	CcSEcCtD
Dipyridamole—PDE7A—Ectoderm Differentiation—TNFRSF11B—Paget's disease of bone	0.00384	0.0318	CbGpPWpGaD
Dipyridamole—Bronchospasm—Pamidronate—Paget's disease of bone	0.00383	0.00435	CcSEcCtD
Dipyridamole—Angioedema—Etidronic acid—Paget's disease of bone	0.00381	0.00434	CcSEcCtD
Dipyridamole—Sweating increased—Pamidronate—Paget's disease of bone	0.00379	0.00431	CcSEcCtD
Dipyridamole—PDE8B—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00378	0.0313	CbGpPWpGaD
Dipyridamole—PDE8A—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00378	0.0313	CbGpPWpGaD
Dipyridamole—Abdominal pain upper—Zoledronate—Paget's disease of bone	0.00376	0.00427	CcSEcCtD
Dipyridamole—Cramp muscle—Zoledronate—Paget's disease of bone	0.0037	0.00421	CcSEcCtD
Dipyridamole—PDE2A—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00368	0.0305	CbGpPWpGaD
Dipyridamole—ADA—p73 transcription factor network—PML—Paget's disease of bone	0.00364	0.0301	CbGpPWpGaD
Dipyridamole—Alopecia—Alendronate—Paget's disease of bone	0.00361	0.0041	CcSEcCtD
Dipyridamole—Dysphagia—Zoledronate—Paget's disease of bone	0.00356	0.00404	CcSEcCtD
Dipyridamole—Arthralgia—Etidronic acid—Paget's disease of bone	0.00355	0.00404	CcSEcCtD
Dipyridamole—Discomfort—Etidronic acid—Paget's disease of bone	0.00351	0.00399	CcSEcCtD
Dipyridamole—Flatulence—Alendronate—Paget's disease of bone	0.0035	0.00398	CcSEcCtD
Dipyridamole—Bronchospasm—Zoledronate—Paget's disease of bone	0.0035	0.00398	CcSEcCtD
Dipyridamole—Dysgeusia—Alendronate—Paget's disease of bone	0.00348	0.00396	CcSEcCtD
Dipyridamole—Sweating increased—Zoledronate—Paget's disease of bone	0.00346	0.00394	CcSEcCtD
Dipyridamole—Muscle spasms—Alendronate—Paget's disease of bone	0.00342	0.00389	CcSEcCtD
Dipyridamole—Abdominal discomfort—Zoledronate—Paget's disease of bone	0.00341	0.00388	CcSEcCtD
Dipyridamole—PDE7B—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00337	0.0279	CbGpPWpGaD
Dipyridamole—Ill-defined disorder—Alendronate—Paget's disease of bone	0.0033	0.00375	CcSEcCtD
Dipyridamole—Haemoglobin—Risedronate—Paget's disease of bone	0.00329	0.00375	CcSEcCtD
Dipyridamole—Anaemia—Alendronate—Paget's disease of bone	0.00329	0.00374	CcSEcCtD
Dipyridamole—Rhinitis—Risedronate—Paget's disease of bone	0.00329	0.00374	CcSEcCtD
Dipyridamole—Haemorrhage—Risedronate—Paget's disease of bone	0.00328	0.00373	CcSEcCtD
Dipyridamole—Pharyngitis—Risedronate—Paget's disease of bone	0.00325	0.0037	CcSEcCtD
Dipyridamole—Angioedema—Alendronate—Paget's disease of bone	0.00325	0.00369	CcSEcCtD
Dipyridamole—Malaise—Alendronate—Paget's disease of bone	0.00321	0.00365	CcSEcCtD
Dipyridamole—Vertigo—Alendronate—Paget's disease of bone	0.00319	0.00363	CcSEcCtD
Dipyridamole—PDE11A—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00313	0.026	CbGpPWpGaD
Dipyridamole—PDE7A—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00313	0.026	CbGpPWpGaD
Dipyridamole—Haemoglobin—Pamidronate—Paget's disease of bone	0.00313	0.00356	CcSEcCtD
Dipyridamole—Rhinitis—Pamidronate—Paget's disease of bone	0.00312	0.00355	CcSEcCtD
Dipyridamole—Haemorrhage—Pamidronate—Paget's disease of bone	0.00312	0.00354	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.0031	0.00353	CcSEcCtD
Dipyridamole—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00306	0.00348	CcSEcCtD
Dipyridamole—Tinnitus—Risedronate—Paget's disease of bone	0.00306	0.00347	CcSEcCtD
Dipyridamole—Cardiac disorder—Risedronate—Paget's disease of bone	0.00304	0.00346	CcSEcCtD
Dipyridamole—Myalgia—Alendronate—Paget's disease of bone	0.00303	0.00344	CcSEcCtD
Dipyridamole—Chest pain—Alendronate—Paget's disease of bone	0.00303	0.00344	CcSEcCtD
Dipyridamole—Dyspepsia—Etidronic acid—Paget's disease of bone	0.003	0.00341	CcSEcCtD
Dipyridamole—Discomfort—Alendronate—Paget's disease of bone	0.00299	0.0034	CcSEcCtD
Dipyridamole—Angiopathy—Risedronate—Paget's disease of bone	0.00297	0.00338	CcSEcCtD
Dipyridamole—Immune system disorder—Risedronate—Paget's disease of bone	0.00296	0.00337	CcSEcCtD
Dipyridamole—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00295	0.00336	CcSEcCtD
Dipyridamole—Arrhythmia—Risedronate—Paget's disease of bone	0.00293	0.00333	CcSEcCtD
Dipyridamole—Bradycardia—Zoledronate—Paget's disease of bone	0.0029	0.00329	CcSEcCtD
Dipyridamole—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00289	0.00329	CcSEcCtD
Dipyridamole—Flushing—Pamidronate—Paget's disease of bone	0.00289	0.00329	CcSEcCtD
Dipyridamole—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00283	0.00322	CcSEcCtD
Dipyridamole—Angiopathy—Pamidronate—Paget's disease of bone	0.00283	0.00321	CcSEcCtD
Dipyridamole—Immune system disorder—Pamidronate—Paget's disease of bone	0.00281	0.0032	CcSEcCtD
Dipyridamole—Flatulence—Risedronate—Paget's disease of bone	0.00281	0.0032	CcSEcCtD
Dipyridamole—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00281	0.00319	CcSEcCtD
Dipyridamole—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00281	0.00319	CcSEcCtD
Dipyridamole—Chills—Pamidronate—Paget's disease of bone	0.0028	0.00318	CcSEcCtD
Dipyridamole—PDE10A—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00279	0.0231	CbGpPWpGaD
Dipyridamole—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00278	0.00317	CcSEcCtD
Dipyridamole—Back pain—Risedronate—Paget's disease of bone	0.00276	0.00314	CcSEcCtD
Dipyridamole—Alopecia—Pamidronate—Paget's disease of bone	0.00275	0.00313	CcSEcCtD
Dipyridamole—Muscle spasms—Risedronate—Paget's disease of bone	0.00274	0.00312	CcSEcCtD
Dipyridamole—Urticaria—Etidronic acid—Paget's disease of bone	0.00271	0.00308	CcSEcCtD
Dipyridamole—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00269	0.00306	CcSEcCtD
Dipyridamole—Tension—Pamidronate—Paget's disease of bone	0.00266	0.00303	CcSEcCtD
Dipyridamole—Dysgeusia—Pamidronate—Paget's disease of bone	0.00266	0.00302	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00264	0.00301	CcSEcCtD
Dipyridamole—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00264	0.003	CcSEcCtD
Dipyridamole—Flushing—Zoledronate—Paget's disease of bone	0.00264	0.003	CcSEcCtD
Dipyridamole—Anaemia—Risedronate—Paget's disease of bone	0.00264	0.003	CcSEcCtD
Dipyridamole—Nervousness—Pamidronate—Paget's disease of bone	0.00263	0.003	CcSEcCtD
Dipyridamole—Back pain—Pamidronate—Paget's disease of bone	0.00262	0.00298	CcSEcCtD
Dipyridamole—Muscle spasms—Pamidronate—Paget's disease of bone	0.00261	0.00297	CcSEcCtD
Dipyridamole—Angioedema—Risedronate—Paget's disease of bone	0.00261	0.00296	CcSEcCtD
Dipyridamole—Angiopathy—Zoledronate—Paget's disease of bone	0.00258	0.00294	CcSEcCtD
Dipyridamole—Immune system disorder—Zoledronate—Paget's disease of bone	0.00257	0.00292	CcSEcCtD
Dipyridamole—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00256	0.00292	CcSEcCtD
Dipyridamole—Vertigo—Risedronate—Paget's disease of bone	0.00256	0.00291	CcSEcCtD
Dipyridamole—Syncope—Risedronate—Paget's disease of bone	0.00256	0.00291	CcSEcCtD
Dipyridamole—Dyspepsia—Alendronate—Paget's disease of bone	0.00255	0.0029	CcSEcCtD
Dipyridamole—Chills—Zoledronate—Paget's disease of bone	0.00255	0.0029	CcSEcCtD
Dipyridamole—Arrhythmia—Zoledronate—Paget's disease of bone	0.00254	0.00289	CcSEcCtD
Dipyridamole—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00252	0.00286	CcSEcCtD
Dipyridamole—Alopecia—Zoledronate—Paget's disease of bone	0.00251	0.00286	CcSEcCtD
Dipyridamole—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00251	0.00285	CcSEcCtD
Dipyridamole—Loss of consciousness—Risedronate—Paget's disease of bone	0.00251	0.00285	CcSEcCtD
Dipyridamole—Anaemia—Pamidronate—Paget's disease of bone	0.00251	0.00285	CcSEcCtD
Dipyridamole—Cough—Risedronate—Paget's disease of bone	0.00249	0.00283	CcSEcCtD
Dipyridamole—Pain—Alendronate—Paget's disease of bone	0.00248	0.00282	CcSEcCtD
Dipyridamole—Angioedema—Pamidronate—Paget's disease of bone	0.00248	0.00282	CcSEcCtD
Dipyridamole—Hypertension—Risedronate—Paget's disease of bone	0.00246	0.0028	CcSEcCtD
Dipyridamole—Malaise—Pamidronate—Paget's disease of bone	0.00245	0.00278	CcSEcCtD
Dipyridamole—Syncope—Pamidronate—Paget's disease of bone	0.00243	0.00277	CcSEcCtD
Dipyridamole—Chest pain—Risedronate—Paget's disease of bone	0.00243	0.00276	CcSEcCtD
Dipyridamole—Myalgia—Risedronate—Paget's disease of bone	0.00243	0.00276	CcSEcCtD
Dipyridamole—Arthralgia—Risedronate—Paget's disease of bone	0.00243	0.00276	CcSEcCtD
Dipyridamole—Dysgeusia—Zoledronate—Paget's disease of bone	0.00243	0.00276	CcSEcCtD
Dipyridamole—Anxiety—Risedronate—Paget's disease of bone	0.00242	0.00275	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00241	0.00274	CcSEcCtD
Dipyridamole—Pruritus—Etidronic acid—Paget's disease of bone	0.00241	0.00274	CcSEcCtD
Dipyridamole—Back pain—Zoledronate—Paget's disease of bone	0.0024	0.00272	CcSEcCtD
Dipyridamole—Feeling abnormal—Alendronate—Paget's disease of bone	0.00239	0.00272	CcSEcCtD
Dipyridamole—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00238	0.00271	CcSEcCtD
Dipyridamole—Muscle spasms—Zoledronate—Paget's disease of bone	0.00238	0.00271	CcSEcCtD
Dipyridamole—Dry mouth—Risedronate—Paget's disease of bone	0.00238	0.0027	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00237	0.0027	CcSEcCtD
Dipyridamole—Cough—Pamidronate—Paget's disease of bone	0.00237	0.00269	CcSEcCtD
Dipyridamole—Convulsion—Pamidronate—Paget's disease of bone	0.00235	0.00267	CcSEcCtD
Dipyridamole—Hypertension—Pamidronate—Paget's disease of bone	0.00234	0.00266	CcSEcCtD
Dipyridamole—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00233	0.00265	CcSEcCtD
Dipyridamole—Tremor—Zoledronate—Paget's disease of bone	0.00232	0.00264	CcSEcCtD
Dipyridamole—Arthralgia—Pamidronate—Paget's disease of bone	0.00231	0.00263	CcSEcCtD
Dipyridamole—Myalgia—Pamidronate—Paget's disease of bone	0.00231	0.00263	CcSEcCtD
Dipyridamole—Urticaria—Alendronate—Paget's disease of bone	0.00231	0.00262	CcSEcCtD
Dipyridamole—Anxiety—Pamidronate—Paget's disease of bone	0.0023	0.00262	CcSEcCtD
Dipyridamole—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.0023	0.00261	CcSEcCtD
Dipyridamole—Abdominal pain—Alendronate—Paget's disease of bone	0.00229	0.00261	CcSEcCtD
Dipyridamole—Shock—Risedronate—Paget's disease of bone	0.00229	0.0026	CcSEcCtD
Dipyridamole—Anaemia—Zoledronate—Paget's disease of bone	0.00229	0.0026	CcSEcCtD
Dipyridamole—Nervous system disorder—Risedronate—Paget's disease of bone	0.00228	0.0026	CcSEcCtD
Dipyridamole—Discomfort—Pamidronate—Paget's disease of bone	0.00228	0.00259	CcSEcCtD
Dipyridamole—Angioedema—Zoledronate—Paget's disease of bone	0.00226	0.00257	CcSEcCtD
Dipyridamole—Skin disorder—Risedronate—Paget's disease of bone	0.00226	0.00257	CcSEcCtD
Dipyridamole—Malaise—Zoledronate—Paget's disease of bone	0.00223	0.00254	CcSEcCtD
Dipyridamole—Vertigo—Zoledronate—Paget's disease of bone	0.00223	0.00253	CcSEcCtD
Dipyridamole—Syncope—Zoledronate—Paget's disease of bone	0.00222	0.00253	CcSEcCtD
Dipyridamole—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00221	0.00252	CcSEcCtD
Dipyridamole—Oedema—Pamidronate—Paget's disease of bone	0.00221	0.00252	CcSEcCtD
Dipyridamole—Palpitations—Zoledronate—Paget's disease of bone	0.00219	0.00249	CcSEcCtD
Dipyridamole—Shock—Pamidronate—Paget's disease of bone	0.00218	0.00248	CcSEcCtD
Dipyridamole—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00218	0.00248	CcSEcCtD
Dipyridamole—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00217	0.00247	CcSEcCtD
Dipyridamole—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00217	0.00246	CcSEcCtD
Dipyridamole—Vomiting—Etidronic acid—Paget's disease of bone	0.00217	0.00246	CcSEcCtD
Dipyridamole—Cough—Zoledronate—Paget's disease of bone	0.00216	0.00246	CcSEcCtD
Dipyridamole—Tachycardia—Pamidronate—Paget's disease of bone	0.00216	0.00246	CcSEcCtD
Dipyridamole—Rash—Etidronic acid—Paget's disease of bone	0.00215	0.00244	CcSEcCtD
Dipyridamole—Convulsion—Zoledronate—Paget's disease of bone	0.00215	0.00244	CcSEcCtD
Dipyridamole—Dermatitis—Etidronic acid—Paget's disease of bone	0.00215	0.00244	CcSEcCtD
Dipyridamole—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00214	0.00243	CcSEcCtD
Dipyridamole—Hypertension—Zoledronate—Paget's disease of bone	0.00214	0.00243	CcSEcCtD
Dipyridamole—Hypersensitivity—Alendronate—Paget's disease of bone	0.00214	0.00243	CcSEcCtD
Dipyridamole—Headache—Etidronic acid—Paget's disease of bone	0.00213	0.00243	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00212	0.00241	CcSEcCtD
Dipyridamole—Chest pain—Zoledronate—Paget's disease of bone	0.00211	0.0024	CcSEcCtD
Dipyridamole—Myalgia—Zoledronate—Paget's disease of bone	0.00211	0.0024	CcSEcCtD
Dipyridamole—Arthralgia—Zoledronate—Paget's disease of bone	0.00211	0.0024	CcSEcCtD
Dipyridamole—Anxiety—Zoledronate—Paget's disease of bone	0.0021	0.00239	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00209	0.00238	CcSEcCtD
Dipyridamole—Paraesthesia—Risedronate—Paget's disease of bone	0.00209	0.00238	CcSEcCtD
Dipyridamole—Discomfort—Zoledronate—Paget's disease of bone	0.00208	0.00237	CcSEcCtD
Dipyridamole—Asthenia—Alendronate—Paget's disease of bone	0.00208	0.00237	CcSEcCtD
Dipyridamole—Dyspnoea—Risedronate—Paget's disease of bone	0.00208	0.00236	CcSEcCtD
Dipyridamole—Hypotension—Pamidronate—Paget's disease of bone	0.00207	0.00235	CcSEcCtD
Dipyridamole—Dry mouth—Zoledronate—Paget's disease of bone	0.00206	0.00235	CcSEcCtD
Dipyridamole—Pruritus—Alendronate—Paget's disease of bone	0.00205	0.00233	CcSEcCtD
Dipyridamole—Dyspepsia—Risedronate—Paget's disease of bone	0.00205	0.00233	CcSEcCtD
Dipyridamole—Nausea—Etidronic acid—Paget's disease of bone	0.00202	0.0023	CcSEcCtD
Dipyridamole—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00202	0.0023	CcSEcCtD
Dipyridamole—Oedema—Zoledronate—Paget's disease of bone	0.00202	0.0023	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00202	0.00229	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00201	0.00229	CcSEcCtD
Dipyridamole—Fatigue—Risedronate—Paget's disease of bone	0.00201	0.00228	CcSEcCtD
Dipyridamole—Pain—Risedronate—Paget's disease of bone	0.00199	0.00226	CcSEcCtD
Dipyridamole—Shock—Zoledronate—Paget's disease of bone	0.00199	0.00226	CcSEcCtD
Dipyridamole—Paraesthesia—Pamidronate—Paget's disease of bone	0.00199	0.00226	CcSEcCtD
Dipyridamole—Diarrhoea—Alendronate—Paget's disease of bone	0.00199	0.00226	CcSEcCtD
Dipyridamole—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00198	0.00225	CcSEcCtD
Dipyridamole—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00198	0.00225	CcSEcCtD
Dipyridamole—Dyspnoea—Pamidronate—Paget's disease of bone	0.00197	0.00224	CcSEcCtD
Dipyridamole—Tachycardia—Zoledronate—Paget's disease of bone	0.00197	0.00224	CcSEcCtD
Dipyridamole—Somnolence—Pamidronate—Paget's disease of bone	0.00197	0.00224	CcSEcCtD
Dipyridamole—Skin disorder—Zoledronate—Paget's disease of bone	0.00196	0.00223	CcSEcCtD
Dipyridamole—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00195	0.00222	CcSEcCtD
Dipyridamole—Dyspepsia—Pamidronate—Paget's disease of bone	0.00195	0.00222	CcSEcCtD
Dipyridamole—Dizziness—Alendronate—Paget's disease of bone	0.00192	0.00218	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00191	0.00217	CcSEcCtD
Dipyridamole—Fatigue—Pamidronate—Paget's disease of bone	0.00191	0.00217	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.0019	0.00217	CcSEcCtD
Dipyridamole—Pain—Pamidronate—Paget's disease of bone	0.00189	0.00215	CcSEcCtD
Dipyridamole—Hypotension—Zoledronate—Paget's disease of bone	0.00189	0.00215	CcSEcCtD
Dipyridamole—Urticaria—Risedronate—Paget's disease of bone	0.00185	0.0021	CcSEcCtD
Dipyridamole—Vomiting—Alendronate—Paget's disease of bone	0.00185	0.0021	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00184	0.00209	CcSEcCtD
Dipyridamole—Abdominal pain—Risedronate—Paget's disease of bone	0.00184	0.00209	CcSEcCtD
Dipyridamole—Rash—Alendronate—Paget's disease of bone	0.00183	0.00208	CcSEcCtD
Dipyridamole—Dermatitis—Alendronate—Paget's disease of bone	0.00183	0.00208	CcSEcCtD
Dipyridamole—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00182	0.00207	CcSEcCtD
Dipyridamole—Headache—Alendronate—Paget's disease of bone	0.00182	0.00207	CcSEcCtD
Dipyridamole—Paraesthesia—Zoledronate—Paget's disease of bone	0.00182	0.00206	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00181	0.00206	CcSEcCtD
Dipyridamole—PDE3B—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00181	0.015	CbGpPWpGaD
Dipyridamole—Dyspnoea—Zoledronate—Paget's disease of bone	0.0018	0.00205	CcSEcCtD
Dipyridamole—Somnolence—Zoledronate—Paget's disease of bone	0.0018	0.00204	CcSEcCtD
Dipyridamole—Dyspepsia—Zoledronate—Paget's disease of bone	0.00178	0.00202	CcSEcCtD
Dipyridamole—Abdominal pain—Pamidronate—Paget's disease of bone	0.00175	0.00199	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00175	0.00198	CcSEcCtD
Dipyridamole—Fatigue—Zoledronate—Paget's disease of bone	0.00174	0.00198	CcSEcCtD
Dipyridamole—SLC29A1—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.00174	0.0144	CbGpPWpGaD
Dipyridamole—Pain—Zoledronate—Paget's disease of bone	0.00173	0.00197	CcSEcCtD
Dipyridamole—Nausea—Alendronate—Paget's disease of bone	0.00172	0.00196	CcSEcCtD
Dipyridamole—ADA—Circadian rythm related genes—PML—Paget's disease of bone	0.00172	0.0143	CbGpPWpGaD
Dipyridamole—Hypersensitivity—Risedronate—Paget's disease of bone	0.00172	0.00195	CcSEcCtD
Dipyridamole—PDE4A—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00169	0.014	CbGpPWpGaD
Dipyridamole—Asthenia—Risedronate—Paget's disease of bone	0.00167	0.0019	CcSEcCtD
Dipyridamole—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00167	0.00189	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00165	0.00188	CcSEcCtD
Dipyridamole—Pruritus—Risedronate—Paget's disease of bone	0.00165	0.00187	CcSEcCtD
Dipyridamole—PDE3A—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00164	0.0136	CbGpPWpGaD
Dipyridamole—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00163	0.00185	CcSEcCtD
Dipyridamole—Urticaria—Zoledronate—Paget's disease of bone	0.00161	0.00183	CcSEcCtD
Dipyridamole—Abdominal pain—Zoledronate—Paget's disease of bone	0.0016	0.00182	CcSEcCtD
Dipyridamole—Diarrhoea—Risedronate—Paget's disease of bone	0.00159	0.00181	CcSEcCtD
Dipyridamole—Asthenia—Pamidronate—Paget's disease of bone	0.00159	0.00181	CcSEcCtD
Dipyridamole—Pruritus—Pamidronate—Paget's disease of bone	0.00157	0.00178	CcSEcCtD
Dipyridamole—PDE1A—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00155	0.0128	CbGpPWpGaD
Dipyridamole—Dizziness—Risedronate—Paget's disease of bone	0.00154	0.00175	CcSEcCtD
Dipyridamole—PDE1C—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00153	0.0127	CbGpPWpGaD
Dipyridamole—Diarrhoea—Pamidronate—Paget's disease of bone	0.00151	0.00172	CcSEcCtD
Dipyridamole—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00149	0.00169	CcSEcCtD
Dipyridamole—Vomiting—Risedronate—Paget's disease of bone	0.00148	0.00168	CcSEcCtD
Dipyridamole—Rash—Risedronate—Paget's disease of bone	0.00147	0.00167	CcSEcCtD
Dipyridamole—Dermatitis—Risedronate—Paget's disease of bone	0.00147	0.00167	CcSEcCtD
Dipyridamole—Dizziness—Pamidronate—Paget's disease of bone	0.00146	0.00166	CcSEcCtD
Dipyridamole—Headache—Risedronate—Paget's disease of bone	0.00146	0.00166	CcSEcCtD
Dipyridamole—Asthenia—Zoledronate—Paget's disease of bone	0.00145	0.00165	CcSEcCtD
Dipyridamole—Pruritus—Zoledronate—Paget's disease of bone	0.00143	0.00163	CcSEcCtD
Dipyridamole—PDE1B—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00141	0.0117	CbGpPWpGaD
Dipyridamole—Vomiting—Pamidronate—Paget's disease of bone	0.00141	0.0016	CcSEcCtD
Dipyridamole—ABCC5—NRF2 pathway—SQSTM1—Paget's disease of bone	0.0014	0.0116	CbGpPWpGaD
Dipyridamole—Rash—Pamidronate—Paget's disease of bone	0.0014	0.00159	CcSEcCtD
Dipyridamole—Dermatitis—Pamidronate—Paget's disease of bone	0.00139	0.00159	CcSEcCtD
Dipyridamole—Headache—Pamidronate—Paget's disease of bone	0.00139	0.00158	CcSEcCtD
Dipyridamole—Diarrhoea—Zoledronate—Paget's disease of bone	0.00138	0.00157	CcSEcCtD
Dipyridamole—Nausea—Risedronate—Paget's disease of bone	0.00138	0.00157	CcSEcCtD
Dipyridamole—PDE2A—Hemostasis—INPP5D—Paget's disease of bone	0.00137	0.0114	CbGpPWpGaD
Dipyridamole—Dizziness—Zoledronate—Paget's disease of bone	0.00134	0.00152	CcSEcCtD
Dipyridamole—Nausea—Pamidronate—Paget's disease of bone	0.00131	0.0015	CcSEcCtD
Dipyridamole—ABCC4—Ectoderm Differentiation—TNFRSF11B—Paget's disease of bone	0.00131	0.0109	CbGpPWpGaD
Dipyridamole—Vomiting—Zoledronate—Paget's disease of bone	0.00129	0.00146	CcSEcCtD
Dipyridamole—Rash—Zoledronate—Paget's disease of bone	0.00127	0.00145	CcSEcCtD
Dipyridamole—Dermatitis—Zoledronate—Paget's disease of bone	0.00127	0.00145	CcSEcCtD
Dipyridamole—Headache—Zoledronate—Paget's disease of bone	0.00127	0.00144	CcSEcCtD
Dipyridamole—PDE6A—Disease—VCP—Paget's disease of bone	0.00123	0.0102	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—VCP—Paget's disease of bone	0.00123	0.0102	CbGpPWpGaD
Dipyridamole—Nausea—Zoledronate—Paget's disease of bone	0.0012	0.00137	CcSEcCtD
Dipyridamole—PDE11A—Hemostasis—INPP5D—Paget's disease of bone	0.00117	0.00968	CbGpPWpGaD
Dipyridamole—ABCC5—Carbohydrate metabolism—NUP205—Paget's disease of bone	0.00116	0.00958	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—INPP5D—Paget's disease of bone	0.00104	0.00863	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—INPP5D—Paget's disease of bone	0.00104	0.00863	CbGpPWpGaD
Dipyridamole—ABCC4—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000969	0.00803	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—NUP205—Paget's disease of bone	0.000941	0.0078	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—NUP205—Paget's disease of bone	0.000941	0.0078	CbGpPWpGaD
Dipyridamole—SLC29A1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000884	0.00733	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—VCP—Paget's disease of bone	0.000862	0.00715	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—VCP—Paget's disease of bone	0.000862	0.00715	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000816	0.00677	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—VCP—Paget's disease of bone	0.000804	0.00667	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—VCP—Paget's disease of bone	0.000793	0.00658	CbGpPWpGaD
Dipyridamole—PDE8A—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000775	0.00643	CbGpPWpGaD
Dipyridamole—PDE8B—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000775	0.00643	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000756	0.00626	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000746	0.00619	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—VCP—Paget's disease of bone	0.000733	0.00608	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—VCP—Paget's disease of bone	0.000733	0.00608	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—VCP—Paget's disease of bone	0.000714	0.00592	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—CALCA—Paget's disease of bone	0.000704	0.00584	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—CALCA—Paget's disease of bone	0.000704	0.00584	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—CALCA—Paget's disease of bone	0.000699	0.00579	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—CALCA—Paget's disease of bone	0.000699	0.00579	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000691	0.00573	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—CALCA—Paget's disease of bone	0.000686	0.00569	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—INPP5D—Paget's disease of bone	0.000674	0.00558	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—NUP205—Paget's disease of bone	0.000666	0.00552	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—VCP—Paget's disease of bone	0.000653	0.00542	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000642	0.00533	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000642	0.00533	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—CALCA—Paget's disease of bone	0.000628	0.0052	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—NUP205—Paget's disease of bone	0.000615	0.0051	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—INPP5D—Paget's disease of bone	0.000613	0.00509	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—VCP—Paget's disease of bone	0.000608	0.00504	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—VCP—Paget's disease of bone	0.000608	0.00504	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—NUP205—Paget's disease of bone	0.000606	0.00503	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—PML—Paget's disease of bone	0.000588	0.00488	CbGpPWpGaD
Dipyridamole—ABCC5—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000586	0.00485	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—CALCA—Paget's disease of bone	0.000583	0.00484	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—CALCA—Paget's disease of bone	0.000583	0.00484	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—INPP5D—Paget's disease of bone	0.000577	0.00478	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000573	0.00475	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—INPP5D—Paget's disease of bone	0.000568	0.00471	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—VCP—Paget's disease of bone	0.000563	0.00467	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—VCP—Paget's disease of bone	0.000556	0.00461	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—VCP—Paget's disease of bone	0.000541	0.00449	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—CALCA—Paget's disease of bone	0.000541	0.00448	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—INPP5D—Paget's disease of bone	0.000528	0.00437	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—CALCA—Paget's disease of bone	0.00052	0.00431	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—SQSTM1—Paget's disease of bone	0.000509	0.00422	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000504	0.00418	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000504	0.00418	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—CALCA—Paget's disease of bone	0.000489	0.00406	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—CALCA—Paget's disease of bone	0.000489	0.00406	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—CALCA—Paget's disease of bone	0.000456	0.00378	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—CALCA—Paget's disease of bone	0.00045	0.00373	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—VCP—Paget's disease of bone	0.000428	0.00355	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—VCP—Paget's disease of bone	0.000428	0.00355	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000428	0.00355	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000428	0.00355	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000417	0.00346	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CALCA—Paget's disease of bone	0.000416	0.00345	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CALCA—Paget's disease of bone	0.000416	0.00345	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000406	0.00336	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CALCA—Paget's disease of bone	0.000405	0.00336	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—INPP5D—Paget's disease of bone	0.0004	0.00331	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—VCP—Paget's disease of bone	0.000392	0.00325	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000382	0.00317	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—NUP205—Paget's disease of bone	0.000377	0.00313	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CALCA—Paget's disease of bone	0.000371	0.00307	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000371	0.00307	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000358	0.00297	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000355	0.00294	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000355	0.00294	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NUP205—Paget's disease of bone	0.000355	0.00294	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VCP—Paget's disease of bone	0.00035	0.0029	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000347	0.00288	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CALCA—Paget's disease of bone	0.000345	0.00286	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CALCA—Paget's disease of bone	0.000345	0.00286	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000338	0.0028	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—CALCA—Paget's disease of bone	0.000337	0.00279	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000329	0.00273	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VCP—Paget's disease of bone	0.000328	0.00272	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NUP205—Paget's disease of bone	0.000327	0.00271	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NUP205—Paget's disease of bone	0.000327	0.00271	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000325	0.00269	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NUP205—Paget's disease of bone	0.000324	0.00269	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—INPP5D—Paget's disease of bone	0.000322	0.00267	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CALCA—Paget's disease of bone	0.00032	0.00265	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VCP—Paget's disease of bone	0.000319	0.00265	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000317	0.00263	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000316	0.00262	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CALCA—Paget's disease of bone	0.000315	0.00261	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—CALCA—Paget's disease of bone	0.000315	0.00261	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PML—Paget's disease of bone	0.000313	0.0026	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CALCA—Paget's disease of bone	0.000307	0.00255	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CALCA—Paget's disease of bone	0.000306	0.00254	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—INPP5D—Paget's disease of bone	0.000302	0.00251	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VCP—Paget's disease of bone	0.0003	0.00249	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NUP205—Paget's disease of bone	0.0003	0.00248	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CALCA—Paget's disease of bone	0.00029	0.00241	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CALCA—Paget's disease of bone	0.000288	0.00239	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PML—Paget's disease of bone	0.000287	0.00238	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—INPP5D—Paget's disease of bone	0.000277	0.00229	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VCP—Paget's disease of bone	0.000274	0.00228	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—NUP205—Paget's disease of bone	0.000274	0.00227	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—SQSTM1—Paget's disease of bone	0.000271	0.00225	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CALCA—Paget's disease of bone	0.000264	0.00219	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—SQSTM1—Paget's disease of bone	0.000248	0.00206	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CALCA—Paget's disease of bone	0.000243	0.00202	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CALCA—Paget's disease of bone	0.000243	0.00202	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—INPP5D—Paget's disease of bone	0.000234	0.00194	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CALCA—Paget's disease of bone	0.000222	0.00184	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000205	0.0017	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CALCA—Paget's disease of bone	0.000199	0.00165	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000192	0.00159	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000186	0.00155	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CALCA—Paget's disease of bone	0.000186	0.00154	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CALCA—Paget's disease of bone	0.000181	0.0015	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000175	0.00145	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CALCA—Paget's disease of bone	0.00017	0.00141	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000161	0.00133	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00016	0.00133	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CALCA—Paget's disease of bone	0.000156	0.00129	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NUP205—Paget's disease of bone	7.54e-05	0.000625	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—INPP5D—Paget's disease of bone	6.43e-05	0.000533	CbGpPWpGaD
